Emergency laparotomies, which most often is performed due to high risk disease (bowel obstruction, ischemia, perforation, etc.), make up 11 % of surgical procedures in emergency surgical departments, however, give rise to 80 % of all postoperative complications. The 30-day mortality rates in relation to these emergent procedures have been reported between 14-30 %, with even higher numbers for frail and older patients. The specific reasons for these outcomes are not yet known, however, a combination of preexisting comorbidities, acute illness, sepsis, and the surgical stress response that arise during- and after the surgical procedure due to the activation of the immunological and humoral system, is most likely to blame. The complex endocrinological response and consequences of this response to emergency surgery are sparsely reported in the literature. The aim of this PHASE project is to evaluate and describe the temporal endocrine, endothelial and immunological changes after major emergency abdominal surgery, and to associate these changes with clinical postoperative outcomes.
Study Type
OBSERVATIONAL
Enrollment
98
* Open, laparoscopic, or laparoscopically-assisted procedures * Procedures involving the stomach, small or large bowel, or rectum for conditions such as perforation, ischaemia, abdominal abscess, bleeding or obstruction
Department of Surgery, Zealand University Hospital
Køge, Denmark
Changes of immunological biomarkers
Assessment of: * plasma inflammatory interleukines incl. IL-1-alfa, IL-1beta, IL-6, IL-10 * plasma TNF-alfa * plasma TGF-beta
Time frame: Change from preoperative levels at postoperative day 5
Number of patients with stress induced hyperglycemia
Assessment of: * Blood glucose, plasma c-peptide, HbA1C * plasma Glucagon-like peptide 1 (GLP-1)
Time frame: Postoperative day 5
Changes of plasma thyroid hormones
Assessment of: * Thyropin-releasing hormone (TRH) * Thyroid-stimulating hormone (TSH) * Thyroid hormones (fT3, fT4, rT3)
Time frame: Change from preoperative levels at postoperative day 5
Changes of the central endocrine stress response
Assessment of plasma corticotropin releasing hormone (CRH)
Time frame: Change from preoperative levels at postoperative day 5
Changes of sE-selectin
Assessment of plasma sE-selectine * sE-selectin * syndecan-1 * thrombomodulin * sVE-cadherin
Time frame: Change from preoperative levels at postoperative day 5
Changes of the endothelial function
Assessed with the non-invasive EndoPAT and expressed as the reactive hyperemia index
Time frame: Change from postoperative day 1 at postoperative day 5
Changes of the periferal endocrine stress response
Assessment of plasma adrenocorticotropic hormone (ACTH)
Time frame: Change from preoperative levels at postoperative day 5
Changes of cortisol
Assessment of plasma cortisol (free and bound)
Time frame: Change from preoperative levels at postoperative day 5
Changes of neuropeptides
Assessment of plasma neuropeptides
Time frame: Change from preoperative levels at postoperative day 5
Changes of syndecan-1
Assessment of plasma syndecan-1
Time frame: Change from preoperative levels at postoperative day 5
Changes of thrombomodulin
Assessment of plasma thrombomodulin
Time frame: Change from preoperative levels at postoperative day 5
Changes of sVE-cadherin
Assessment of plasma sVE-cadherin
Time frame: Change from preoperative levels at postoperative day 5
Number of patients with major adverse cardiovascular events
Defined as: * Cardiovascular death * Myocardial injury within postoperative day 4 (definition: peak plasma cardiac troponin-I ≥ 45ng/L (99th percentile URL, 10% CV at 40ng/L)) * Acute coronary syndrome (unstable angina pectoris, NSTEMI, STEMI) * Congestive heart failure * Stroke * Nonfatal cardiac arrest * New clinically important cardiac arrhythmia * Coronary revascularization procedure (PCI or CABG) * Sudden unexpected death
Time frame: 365 days after surgery
Number of patients with postoperative non-cardiovascular complications
Defined as: * Non-cardiovascular death with other defined reason for death * Sepsis (sepsis - severe sepsis - septic shock) * Pneumonia * Respiratory failure * Surgical complications (Clavien-Dindo stage 3) * Any non-cardiovascular life-threatening complication (Clavien-Dindo stage 4) * Readmission due to a non-cardiovascular complication
Time frame: 365 days after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.